Molecular etiopathogenesis of spinal muscular atrophy

被引:0
|
作者
Tomek, A [1 ]
Matoska, V [1 ]
Goetz, P [1 ]
Hedvicáková, P [1 ]
Bauer, P [1 ]
Bóday, A [1 ]
机构
[1] LF UK FN Motol, Neurol Klin 2, Prague 15000 5, Czech Republic
关键词
ethiopathogenesis; spinal muscular atrophy;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinal muscular atrophy (SMA) is an autosomal recesive hereditary disease caused by premature atrophy of motor neurons of the anterior spinal horns. With regard to the severity of the disease three types of SMA are described: SMA I, II, III. SMA is caused by mutations by the gene Survival Motor Neuron I (SMNI). Gene SMNI is on chromosome 5q13, which contains many repetitive sequences and pseudogenes. Among the pseudogenes is also gene SMN2 which differs from gene SMNI only in 6 nucleotides. The product of gene SMN1, and to a smaller extent SMN2, is protein SMN which participates in the posttranscription metabolism of mRNA of all cell types and in a not too well known way also in the metabolism of the alpha-motor neurons of the anterior spinal horns. Protein SMN has several splicing isoforms. 90% of all transcripts of the SMN1 gene is complete and fully functional. They have all 7 exons. An opposite situation is found in transcription of gene SMN2 where only 10-30% transcripts are fully functional, it contains all 7 exons. The severity of the disease depends on the presence of the amount of functional molecules of protein SMN. The most frequent mutation are deletions comprising in 93% patients exon 7 and 8 of gene SMN1. In 3-6% patients an isolated deletion of exon 7 is involved. Less frequent are point mutations (1-2 patients with SM I, 4-5% patients with SMA II and III); so far some 20 patients were identified and 20 different point mutations. Another mechanism of development of mutations in gene SMN1 is gene conversion of gene SMN1 to gene SMN2. This mechanism explains also the increase of the number of copies of SMN2.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [1] Spinal Muscular Atrophy: Molecular Mechanisms
    Farrar, M. A.
    Johnston, H. M.
    Grattan-Smith, P.
    Turner, A.
    Kiernan, M. C.
    [J]. CURRENT MOLECULAR MEDICINE, 2009, 9 (07) : 851 - 862
  • [2] Molecular mechanisms of spinal muscular atrophy
    Sumner, Charlotte J.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2007, 22 (08) : 979 - 989
  • [3] Molecular diagnosis of spinal muscular atrophy
    Stewart, H
    Wallace, A
    McGaughran, J
    Mountford, R
    Kingston, H
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 78 (06) : 531 - 535
  • [4] Molecular genetics of spinal muscular atrophy
    Melki, J
    Munnich, A
    [J]. TRENDS IN CHILD NEUROLOGY - A FESTSCHRIFT FOR JEAN AICARDI, 1996, : 137 - 141
  • [5] The molecular bases of spinal muscular atrophy
    Frugier, T
    Nicole, S
    Cifuentes-Diaz, C
    Melki, J
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (03) : 294 - 298
  • [6] Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
    Ahmad, Saif
    Bhatia, Kanchan
    Kannan, Annapoorna
    Gangwani, Laxman
    [J]. JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2016, 10 : 39 - 49
  • [7] Analysis of the molecular basis of spinal muscular atrophy
    Fischer, U.
    [J]. NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 645 - 645
  • [8] Molecular evaluation in infantile spinal muscular atrophy
    Vinas P, Carlos I.
    Martin H, Ivonne
    Zaldivar, Tatiana, V
    Garofalo G, Nicolas
    Zayas G, Mariesky
    Guerra B, Rosa
    Margarita N, Lucia
    Vargas D, Jose
    Gutierrez G, Joel
    [J]. REVISTA CHILENA DE PEDIATRIA-CHILE, 2013, 84 (05): : 499 - 504
  • [9] Molecular pathogenesis of spinal and bulbar muscular atrophy
    Merry, DE
    [J]. BRAIN RESEARCH BULLETIN, 2001, 56 (3-4) : 203 - 207
  • [10] Clinical and molecular diagnosis of spinal muscular atrophy
    Panigrahi, I
    Kesari, A
    Phadke, SR
    Mittal, B
    [J]. NEUROLOGY INDIA, 2002, 50 (02) : 117 - 122